Prognostic value of baseline 18F-FDG PET/CT metabolic parameters in EGFR-mutant lung adenocarcinoma patients treated with EGFR-TKIs
{{output}}
Objective: To investigate the correlation between baseline 1⁸F-FDG PET/CT metabolic parameters and progression-free survival (PFS) in EGFR-mutant lung adenocarcinoma receiving EGFR-TKI treatment, with subgroup analysis for exon ... ...
